Acute leukaemia of adults in Auckland: biological characteristics and survival.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D001853:Bone Marrow / Q000473:pathology; D001856:Bone Marrow Examination; D005260:Female; D006801:Humans; D004915:Leukemia, Erythroblastic, Acute / Q000188:drug therapy / Q000401:mortality*; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000401:mortality*; D007948:Leukemia, Monocytic, Acute / Q000188:drug therapy / Q000401:mortality*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000401:mortality*; D007958:Leukocyte Count; D008136:Longevity; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use*; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use*; D011379:Prognosis; D012737:Sex Factors; D014750:Vincristine / Q000627:therapeutic use*
D014750:Vincristine; D015122:Mercaptopurine; D011241:Prednisone